What are the Key Factors Contributing to Surge of Medical Aesthetics Market?

The ability of the medical aesthetic treatments to provide enhanced physical appearance and thus, higher self-esteem and better psychological state is making these treatments highly sought-after across the world. Medical aesthetic treatments like botox play a major role in alleviating the problems of migraines and excessive sweating. 

Additionally, these advancements have caused a drastic reduction in the recovery time periods. Medical aesthetics procedures help people improve their physical appearance, which, in turn, helps them achieve high self-esteem. Treatment procedures such as Botox can help people deal with migraines and excessive sweating. When Botox is administered into the armpits of patients, it paralyzes the armpit’s sweat glands immediately, which subsequently leads to the release of lesser sweat than before. 

The rapid technological advancements and innovations in laser technology are significantly boosting the popularity of cosmetic procedures across the world. Owing to these advancements, laser-based procedures can now provide many benefits such as reduced intensity of pain and faster recovery times. Advanced laser technologies such as transdermal focussed ultrasound, higher intensity focused ultrasound (HIFU), and monopolar RF are widely used in many aesthetic treatments, such as fat reduction and body contouring. The rising popularity of various cosmetic procedures, owing to the development of advanced laser technologies, will further propel the demand for medical aesthetic treatments across the world.

Browse Detailed Analysis @ Medical Aesthetics Industry Growth

Due to the above-mentioned factors, the global medical aesthetics market is expected to witness substantial growth in the coming years. Medical aesthetics refer to a branch of scientific research that uses minimally invasive treatments in order to improve a person’s physical appearance through the use of lasers or other energy based devices and healthcare and beauty services. Medical aesthetics are commonly used in the treatment of fine lines and wrinkles, scars, and stretch marks, fat reduction, body contours, skin oxygenation and rejuvenation, skin tightening, and many other types of problems related to physical aesthetics.

This study covers

•             Major factors driving the market and their impact during the short, medium, and long terms

•             Market restraints and their impact during the short, medium, and long terms

•             Recent trends and evolving opportunities for the market participants

•             Historical and the present size of the market segments and understand their comparative future potential

•             Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings

•             Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders

Read More

How Will Low Storage Space Requirement Strengthen France LPG Market?

A number of factors such as the low upfront cost and less storage space required by LPG boilers and the massive government support toward new energy vehicles will help the French LPG market demonstrate a CAGR of 2.1% between 2020 and 2030. According to P&S Intelligence, the market was valued at $7,691.2 million in 2020, and it will generate $9,480.3 million revenue by 2030. Additionally, the rising public awareness regarding environmental pollution will also propel the demand for LPG in France.

The low upfront cost of LPG boilers is one of the primary growth drivers of the French LPG market. As compared to an electric heat pump or automatic-fed biomass boiler, an LPG boiler is available at a very low cost. Additionally, the upfront cost of LPG boilers is also lower than air source heat pumps. In addition, the easy storage of LPG is also a key contributor to the industry growth, as wood chip fuel and wood pellet storage requires minimum ventilation standards for preventing off-gassing or buildup of toxic gases.

The industrial category, under the industrial segment, is expected to demonstrate the fastest growth in the French LPG market throughout this decade. This will be on account of the increasing use of LPG for space and process heating, powering forklifts, manufacturing packaging materials, food production, and powering industrial ovens. In addition, a high volume of LPG is also being used as fuel in furnaces and kilns. The wide application base of LPG in the industrial sector can be credited to the high calorific value of this gas. It is primarily used in applications, including cooking, hot air balloons, agriculture, and transportation (Autogas).

At present, the French LPG industry is consolidated in nature, due to the presence of four dominant players, namely Antargaz, Rubis SCA (Vitogaz), Primagaz, and DCC plc (Butagaz). In recent years, these players have been adopting different strategic measures, including product launches and acquisitions, to stay ahead of their competitors in the market. For example, in July 2021, Antargaz acquired Redéo Énergies as part of its ongoing efforts to expand the portfolio of its multi-energy offerings. With this move, Antargaz aims at introducing a new solution that combines green energy and local production. 

Therefore, the low upfront cost of LPG boilers and the low storage space required for LPG gas are the key contributors to the market growth in France.

Read More

How Will Hospitality Sector Strengthen Kuwait Facility Management Market?

The Kuwaiti facility management market is expected to grow at a CAGR of 8.5% between 2021 and 2030, owing to the booming hospitality sector and upcoming infrastructure projects in the country. According to P&S Intelligence, the industry was valued at $954.4 million in 2021, and it will generate $1,995.5 million revenue by 2030. In recent years, economic diversification has become a major trend in the market. To decrease its reliance on the energy sector, the government is focusing on increasing investments in the tourism, construction, and hospitality sectors to reduce its dependence on oil revenue.

One of the major growth drivers of the Kuwaiti facility management market is the flourishing hospitality sector, owing to the increasing footfall of tourists in the country. According to the WorldData, a total of 2 million tourists visited Kuwait in 2020. The government is encouraging private investments, constructing new attractions, increasing international promotion campaigns, and expanding airport capacity to boost the hospitality sector in the nation. The surging tourist footfall and soaring government support for the hospitality sector will result in the construction of hospitality units, which require facility management services to offer more comfort to customers.

The property category, within the service segment, accounted for the largest share in the Kuwaiti facility management industry in 2021. Whereas, the cleaning category is expected to register the fastest growth in the market throughout this decade. This will be due to the rising expectation for cleaning, germfree, and hygienic public spaces and workspaces, on account of the ongoing COVID-19 pandemic. To deal with the safety quotient of sanitation, enterprises and government organizations are using innovative scanners and sensors in facility management equipment.

With the presence of numerous players, the Kuwaiti facility management market is fragmented in nature, owing to which the competition has increased considerably. Nowadays, the market players are focusing on different strategic measures, such as contract wins and product launches, to gain a competitive edge. Some of the leading players in the market include Kharafi National for Infrastructure Projects Developments Construction and Services S.A.E., R&E Petroleum Co., and Fawaz Trading & Engineering Services Co. W.L.L.

Thus, the expanding hospitalization sector will steer the demand for facility management services in Kuwait.

Read More

Rising Incidence of Healthcare Associated Infections Fueling Expansion of Sterilization Technology Market

The healthcare industry deals with sensitive issues, which is why it is of utmost importance that the devices in hospital settings are cleaned after every single use and are maintained properly for providing the patients with quality care. If the medical devices are not cleaned on a regular basis, patients and healthcare professionals both can get infected. One of the major reasons for the rising prevalence of hospital-acquired diseases is the poor level of cleanliness in different medical settings. However, the regulations regarding the proper maintenance of all medical devices are becoming more stringent, which is resulting in the growing adoption of the sterilization technology.

Attributed to these reasons, the sterilization technology market is predicted to register significant growth in the coming years. Devices and consumables both make use of the sterilization technology, among which medical devices made the most use of this technology in the past. Different types of sterilizers which are used for sterilizing medical devices are ultrasonic sterilizers, steam sterilizers, liquid sterilizers, low temperature sterilizers, filtration sterilizers, heat sterilizers, and radiation sterilizers. Out of these, the demand for heat sterilizers is expected to increase significantly in the coming years for sterilizing products that are moisture sensitive. The vendors in the domain offer two types of sterilization services, namely sterilization validation and contract sterilization.

In the past, North America emerged as the largest sterilization technology market, owing to the presence of large number of hospitals, rising prevalence of hospital-acquired diseases, and expansion of medical devices and pharmaceutical industries in the region. Furthermore, the increasing number of surgeries and growing healthcare expenditure in the region are also resulting in the rising adoption of sterilization. Other than this, the demand for this technology is also predicted to grow substantially in the Asia-Pacific region in the coming years, on account of growing medical tourism and increasing healthcare expenditure. 

Read More

Increasing Prevalence of Skin Diseases Powering Muscle Relaxant Drug Sales

With the rising incidence of skin diseases, the demand for muscle relaxant drugs is surging sharply across the world. Some of the major factors fueling the incidence of these diseases are the increasing pollution levels, the excessive exposure to ultraviolet (UV) radiation, and increasing tobacco and alcohol consumption. Moreover, exposure to UV rays causes reduction in skin elasticity and also makes the skin highly vulnerable to sunburns, thereby pushing up the requirement for muscle relaxant drugs.

Apart from the aforementioned factor, the rising prevalence of acne is also powering the sales of muscle relaxant drugs around the world. This is because botulinum toxin-based muscle relaxant procedures are required for treating this disease. The surging spending on various facial aesthetic treatment procedures, on account of the growing disposable income of people, and the soaring usage of neuromuscular blocking agents in surgeries are also powering the sales of these drugs.

Geographically, the demand for muscle relaxant drugs was observed to be the highest in North America in the years gone by. This was because of the large-scale usage of facial muscle relaxants and the existence of a large geriatric population in the region. On the other hand, in the forthcoming years, the sales of these drugs will shoot up in Asia, primarily due to the rapidly improving healthcare infrastructure and the increasing volume of surgeries being performed in the region.

Hence, it can be said without any hesitation that the demand for muscle relaxant drugs will rise enormously in the years to come, primarily because of the growing incidence of skin diseases and the ballooning population of ageing people all over the world.

Read More

Sleeping Aids Providing Comfort to Sleep Apnea Patients

 The American Sleep Apnea Association says that at present, around 22 million people in the U.S. suffer from sleep apnea. Among these, around 80% of cases of severe and moderate obstructive sleep apnea (OSA) remain undiagnosed. OSA can affect infants as well as adults; however, it is most frequent among men over 40 years. This disorder is highly prevalent among overweight or obese men. Thus, the surging cases of sleep disorders, such as OSA and insomnia, will create a huge requirement for sleeping aids in the coming years.

Browse detailed report with COVID-19 impact analysis on Sleeping Aids Market Report

In recent years, BRAEBON Medical Corporation, Takeda Pharmaceutical Company Limited, Löwenstein Medical GmbH & Co. KG, Natus Medical Incorporated, GlaxoSmithKline plc, Merck & Co. Inc., ResMed Inc., and Koninklijke Philips N.V. have been focusing on the production of sleep apnea devices, mattress and pillows, and medication and offering sleep laboratory services. In contemporary times, mattresses and pillows are being preferred over other sleeping aids due to their cost-effectiveness and availability in wide varieties. These products are used to comfort and treat patients suffering from insomnia, sleep apnea, narcolepsy, restless leg syndrome (RLS), and sleepwalking.

Currently, sleeping aids manufacturers are engaging in product launches and partnerships and collaborations to reach out to a greater number of customers. For instance, in September 2019, Koninklijke Philips N.V. introduced its expanded SmartSleep suite of solutions in the U.S. These solutions assist users in addressing an array of sleep issues, ranging from difficulty in falling asleep to snoring. Furthermore, in January 2020, SleepScore Labs partnered with Serta Simmons Bedding LLC (SSB) to explore the effects of sleeping on the iComfort by Serta CF4000 mattress and its ability to offer restful and comfortable sleep.

Whereas, the Asia-Pacific (APAC) sleeping aids market is expected to progress at the highest rate in the foreseeable future. This will be due to the increasing consumption of sleeping pills, booming geriatric population, and rising burden of sleeping disorders. According to the United Nations Population Fund (UNFPA), the population of people aged 60 years or above in the region will reach around 1.3 billion by 2050. Moreover, the low manufacturing cost of the products, owing to the easy availability of raw materials and labor, will support the market growth in the region.

Thus, the mounting cases of sleeping disorders and escalating demand for sleeping pills will fuel the adoption of sleeping aids.

Read More

Increasing Research Activities Drive Development of Catalog Peptides

Every year, over 9.5 million people die of cancer each year, according to the World Health Organization (WHO). This is because either patients are diagnosed in later stages, or the drugs aren’t able to target tumors that well. A lot of cancers are formed due to the disruption in the pathways activated by peptides, which are essentially short chains of amino acids; a peptide of more than 50 amino acids is known as a protein. Since the establishment of the fact that protein pathway disruption is a potential cause of cancer, extensive research and development (R&D) has been put in to remedy this.

Browse detailed report with COVID-19 impact analysis on Catalog Peptides Market Competitive Landscape

Thus, with the rising prevalence of cancer and fruitful R&D, the catalog peptides market is predicted to grow from $238.4 million in 2018 to $332.1 million by 2024, at a 5.8% CAGR during 2019–2024 (forecast period). The term catalog peptide refers to the artificially synthesized peptide drugs which are readily available with biotechnology and pharmaceutical companies, as opposed to those that are customized as per user preference and the specific application.

Presently, North America makes the largest contribution to the catalog peptides market, owing to the presence of a number of biopharmaceutical companies, increasing R&D investments for widening the application area of such products, and adoption of improved technologies for manufacturing. Within the region, the U.S. consumes such drugs in higher amounts, owing to its increasing incidence of chronic diseases, especially cancer. Moreover, numerous drugs are receiving approvals from the Food and Drug Administration, which is leading to their rising availability for the treatment of various diseases.

Hence, with the rising R&D activities and prevalence of cancer, the demand for catalog peptides will also grow.

Read More